Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.2200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.2100/ 1
- Ask / Lots4.9900/ 5
- Open / Previous Close--- / 4.2200
- Day Range---
- 52 Week Range
- Volume10
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 29188 | 4.1464 |
| 09:34 ET | 22509 | 4.0322 |
| 09:36 ET | 15357 | 4.05 |
| 09:38 ET | 4923 | 4.04 |
| 09:39 ET | 104260 | 4.05 |
| 09:41 ET | 2300 | 4.065 |
| 09:43 ET | 15595 | 4.105 |
| 09:45 ET | 31178 | 4.2 |
| 09:48 ET | 34400 | 4.16 |
| 09:50 ET | 4402 | 4.15 |
| 09:52 ET | 9002 | 4.1829 |
| 09:54 ET | 19975 | 4.12 |
| 09:56 ET | 4277 | 4.18 |
| 09:57 ET | 15328 | 4.24 |
| 09:59 ET | 68284 | 4.22 |
| 10:01 ET | 6646 | 4.2 |
| 10:03 ET | 4633 | 4.1901 |
| 10:06 ET | 5971 | 4.165 |
| 10:08 ET | 6046 | 4.2039 |
| 10:10 ET | 30437 | 4.215 |
| 10:12 ET | 5525 | 4.175 |
| 10:14 ET | 12595 | 4.19 |
| 10:15 ET | 9650 | 4.195 |
| 10:17 ET | 2068 | 4.1938 |
| 10:19 ET | 1929 | 4.23 |
| 10:21 ET | 637 | 4.22 |
| 10:24 ET | 637 | 4.22 |
| 10:26 ET | 4993 | 4.25 |
| 10:28 ET | 1000 | 4.23 |
| 10:30 ET | 300 | 4.23 |
| 10:32 ET | 8619 | 4.2 |
| 10:33 ET | 2000 | 4.2001 |
| 10:35 ET | 5300 | 4.205 |
| 10:37 ET | 1113 | 4.22 |
| 10:39 ET | 100 | 4.235 |
| 10:42 ET | 8200 | 4.231 |
| 10:44 ET | 200 | 4.24 |
| 10:46 ET | 19498 | 4.23 |
| 10:48 ET | 600 | 4.215 |
| 10:50 ET | 3100 | 4.21 |
| 10:53 ET | 6475 | 4.22 |
| 10:55 ET | 5578 | 4.2278 |
| 10:57 ET | 752 | 4.23 |
| 11:00 ET | 4600 | 4.225 |
| 11:02 ET | 13579 | 4.26 |
| 11:04 ET | 41836 | 4.255 |
| 11:06 ET | 9185 | 4.285 |
| 11:08 ET | 15864 | 4.295 |
| 11:09 ET | 4918 | 4.28 |
| 11:11 ET | 5755 | 4.265 |
| 11:13 ET | 2733 | 4.265 |
| 11:15 ET | 3723 | 4.23 |
| 11:18 ET | 900 | 4.225 |
| 11:20 ET | 350 | 4.23 |
| 11:22 ET | 1400 | 4.23 |
| 11:24 ET | 17149 | 4.195 |
| 11:26 ET | 3184 | 4.17 |
| 11:27 ET | 7100 | 4.1608 |
| 11:29 ET | 11049 | 4.195 |
| 11:31 ET | 7750 | 4.205 |
| 11:33 ET | 5004 | 4.2 |
| 11:36 ET | 1800 | 4.205 |
| 11:38 ET | 600 | 4.205 |
| 11:40 ET | 13293 | 4.2083 |
| 11:42 ET | 300 | 4.21 |
| 11:44 ET | 800 | 4.2 |
| 11:45 ET | 1550 | 4.205 |
| 11:47 ET | 20141 | 4.155 |
| 11:49 ET | 2487 | 4.1495 |
| 11:51 ET | 9499 | 4.125 |
| 11:54 ET | 3900 | 4.13 |
| 11:56 ET | 3082 | 4.155 |
| 11:58 ET | 14881 | 4.21 |
| 12:00 ET | 4405 | 4.225 |
| 12:02 ET | 1200 | 4.2209 |
| 12:03 ET | 200 | 4.225 |
| 12:05 ET | 352 | 4.225 |
| 12:07 ET | 2113 | 4.215 |
| 12:09 ET | 2944 | 4.235 |
| 12:12 ET | 8199 | 4.25 |
| 12:14 ET | 5884 | 4.24 |
| 12:16 ET | 800 | 4.235 |
| 12:18 ET | 1400 | 4.235 |
| 12:20 ET | 350 | 4.231 |
| 12:21 ET | 5128 | 4.235 |
| 12:23 ET | 526 | 4.235 |
| 12:25 ET | 1800 | 4.235 |
| 12:27 ET | 12078 | 4.205 |
| 12:30 ET | 2500 | 4.205 |
| 12:32 ET | 1933 | 4.2 |
| 12:34 ET | 7394 | 4.195 |
| 12:36 ET | 2385 | 4.19 |
| 12:38 ET | 2745 | 4.2 |
| 12:43 ET | 500 | 4.2 |
| 12:45 ET | 1526 | 4.2 |
| 12:50 ET | 200 | 4.195 |
| 12:52 ET | 540 | 4.195 |
| 12:54 ET | 300 | 4.195 |
| 12:56 ET | 5770 | 4.2 |
| 12:57 ET | 2372 | 4.2 |
| 12:59 ET | 300 | 4.2 |
| 01:03 ET | 1100 | 4.2 |
| 01:06 ET | 4690 | 4.2 |
| 01:08 ET | 3100 | 4.205 |
| 01:10 ET | 100 | 4.205 |
| 01:12 ET | 200 | 4.21 |
| 01:14 ET | 100 | 4.21 |
| 01:15 ET | 100 | 4.21 |
| 01:17 ET | 200 | 4.205 |
| 01:19 ET | 250 | 4.204 |
| 01:24 ET | 100 | 4.205 |
| 01:26 ET | 7421 | 4.22 |
| 01:32 ET | 2743 | 4.21 |
| 01:33 ET | 200 | 4.215 |
| 01:35 ET | 100 | 4.22 |
| 01:37 ET | 300 | 4.215 |
| 01:42 ET | 100 | 4.215 |
| 01:46 ET | 1000 | 4.175 |
| 01:48 ET | 2200 | 4.19 |
| 01:50 ET | 6440 | 4.2107 |
| 01:51 ET | 1846 | 4.2 |
| 01:55 ET | 2821 | 4.22 |
| 01:57 ET | 400 | 4.22 |
| 02:00 ET | 615 | 4.225 |
| 02:02 ET | 8872 | 4.28 |
| 02:04 ET | 3116 | 4.3 |
| 02:06 ET | 4056 | 4.2909 |
| 02:08 ET | 3269 | 4.295 |
| 02:09 ET | 27892 | 4.22 |
| 02:11 ET | 8382 | 4.24 |
| 02:13 ET | 1000 | 4.19 |
| 02:15 ET | 1832 | 4.23 |
| 02:18 ET | 4062 | 4.22 |
| 02:20 ET | 1456 | 4.23 |
| 02:22 ET | 2117 | 4.24 |
| 02:24 ET | 2481 | 4.2498 |
| 02:26 ET | 800 | 4.245 |
| 02:27 ET | 5636 | 4.255 |
| 02:29 ET | 1188 | 4.26 |
| 02:31 ET | 400 | 4.255 |
| 02:33 ET | 3647 | 4.27 |
| 02:36 ET | 634 | 4.265 |
| 02:38 ET | 11867 | 4.24 |
| 02:40 ET | 904 | 4.265 |
| 02:42 ET | 1100 | 4.265 |
| 02:44 ET | 1450 | 4.25 |
| 02:45 ET | 6652 | 4.24 |
| 02:47 ET | 4600 | 4.235 |
| 02:49 ET | 6800 | 4.24 |
| 02:51 ET | 3212 | 4.235 |
| 02:54 ET | 2593 | 4.255 |
| 02:56 ET | 6753 | 4.245 |
| 02:58 ET | 1000 | 4.25 |
| 03:00 ET | 1200 | 4.255 |
| 03:02 ET | 800 | 4.235 |
| 03:03 ET | 13295 | 4.23 |
| 03:05 ET | 1441 | 4.225 |
| 03:07 ET | 2018 | 4.2201 |
| 03:09 ET | 865 | 4.225 |
| 03:12 ET | 2709 | 4.22 |
| 03:14 ET | 4172 | 4.235 |
| 03:16 ET | 6306 | 4.245 |
| 03:18 ET | 200 | 4.245 |
| 03:20 ET | 1178 | 4.245 |
| 03:21 ET | 14223 | 4.22 |
| 03:23 ET | 7699 | 4.245 |
| 03:25 ET | 600 | 4.235 |
| 03:27 ET | 4523 | 4.27 |
| 03:30 ET | 2938 | 4.275 |
| 03:32 ET | 2302 | 4.28 |
| 03:34 ET | 2300 | 4.275 |
| 03:36 ET | 1400 | 4.275 |
| 03:38 ET | 10559 | 4.25 |
| 03:39 ET | 2076 | 4.25 |
| 03:41 ET | 1300 | 4.24 |
| 03:43 ET | 3800 | 4.255 |
| 03:45 ET | 2826 | 4.255 |
| 03:48 ET | 2789 | 4.245 |
| 03:50 ET | 3533 | 4.25 |
| 03:52 ET | 2793 | 4.245 |
| 03:54 ET | 4159 | 4.245 |
| 03:56 ET | 4068 | 4.245 |
| 03:57 ET | 6999 | 4.215 |
| 03:59 ET | 36495 | 4.22 |
Sep 17, 2024
DJ Mereo BioPharma Group Down Over 9%, on Pace for Largest Percent Decrease Since August 2023 -- Data Talk, from 1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
1:42PM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 16, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:21PM ET on Monday Sep 16, 2024 by Dow Jones
12:21PM ET on Monday Sep 16, 2024 by Dow Jones
Sep 12, 2024
Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference, from 5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
5:35PM ET on Thursday Sep 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 649.3M | -12.9x | --- |
4D Molecular Therapeutics Inc | 874.1M | -7.6x | --- |
Applied Therapeutics Inc | 901.5M | -5.2x | --- |
Immunome Inc | 930.8M | -2.8x | --- |
Stoke Therapeutics Inc | 801.3M | -7.0x | --- |
Arbutus Biopharma Corp | 779.7M | -9.4x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $649.3M |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $-0.33 |
Book Value | $0.46 |
P/E Ratio | -12.9x |
Price/Sales (TTM) | 62.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
